An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects
暂无分享,去创建一个
Alban Redheuil | Philippe Cluzel | Philippe Giral | Antonio Gallo | Antonino Di Pino | P. Cluzel | A. Redheuil | P. Giral | E. Bruckert | S. Piro | F. Purrello | D. Rosenbaum | Eric Bruckert | David Rosenbaum | Roberto Scicali | Salvatore Piro | Agata Maria Rabuazzo | Francesco Purrello | A. Gallo | R. Scicali | A. M. Rabuazzo | A. Pino | Roberto Scicali
[1] John A. Rumberger,et al. Interplay of Coronary Artery Calcification and Traditional Risk Factors for the Prediction of All-Cause Mortality in Asymptomatic Individuals , 2012, Circulation. Cardiovascular imaging.
[2] M. Fasshauer,et al. Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.
[3] J. Seidell. Prevalence and time trends of obesity in Europe , 2002, Journal of endocrinological investigation.
[4] J. Hokanson,et al. Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calcium , 2004, International Journal of Obesity.
[5] D. McGee,et al. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. , 2005, Annals of epidemiology.
[6] Contribution of gender and body fat distribution to inflammatory marker concentrations in apparently healthy young adults , 2012, Inflammation Research.
[7] S. Yusuf,et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.
[8] Sekar Kathiresan,et al. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease , 2017, JAMA.
[9] D. Goff,et al. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. , 2016, Journal of the American College of Cardiology.
[10] T. Hansen,et al. Measures of overweight and obesity and risk of cardiovascular disease: a population-based study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[11] S. Grundy,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[12] S. Grundy,et al. Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management , 2004, Arteriosclerosis, Thrombosis and Vascular Biology.
[13] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[14] A Ross Naylor,et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.
[15] D. Berman,et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. , 2004, Journal of the American College of Cardiology.
[16] Melanie J. Cowan,et al. The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. , 2016, American journal of public health.
[17] N. Yamakita,et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. , 2001, Diabetes care.
[18] O. Svendsen. Should measurement of body composition influence therapy for obesity? , 2003, Acta Diabetologica.
[19] Udo Hoffmann,et al. Diagnostic and prognostic value of absence of coronary artery calcification. , 2009, JACC. Cardiovascular imaging.
[20] C A Emdin,et al. Apfeltyp erhöht Diabetes- und KHK-Risiko , 2017, DMW - Deutsche Medizinische Wochenschrift.
[21] P. Schlattmann,et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis , 2013, European Journal of Clinical Nutrition.
[22] V. Aboyans,et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). , 2018, Revista espanola de cardiologia.
[23] Børge G Nordestgaard,et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial , 2009, The Lancet.
[24] R. Collins,et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.
[25] D. Bonaduce,et al. Prognostic value of coronary artery calcium score and coronary CT angiography in patients with intermediate risk of coronary artery disease , 2012, The International Journal of Cardiovascular Imaging.
[26] H. Hecht. Coronary Artery Calcium Imaging , 2011 .
[27] P. Cluzel,et al. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients. , 2016, Atherosclerosis.
[28] M. Visser,et al. What aspects of body fat are particularly hazardous and how do we measure them? , 2006, International journal of epidemiology.
[29] Relationship between non–high-density lipoprotein cholesterol and carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults , 2017, Lipids in Health and Disease.
[30] D. Jacobs,et al. Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 2007, The American journal of clinical nutrition.
[31] Daniel S Berman,et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. , 2007, Journal of the American College of Cardiology.
[32] E. Oda. Metabolic syndrome: its history, mechanisms, and limitations , 2012, Acta Diabetologica.
[33] K. Watson,et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. , 2008, Archives of internal medicine.
[34] E. Barrett-Connor,et al. A prospective study of abdominal obesity and coronary artery calcium progression in older adults. , 2009, The Journal of clinical endocrinology and metabolism.
[35] E. V. van Beek,et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. , 2007, The Journal of clinical endocrinology and metabolism.
[36] W. James,et al. WHO recognition of the global obesity epidemic , 2008, International Journal of Obesity.
[37] K. Strissel,et al. Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease , 2014, Current opinion in endocrinology, diabetes, and obesity.
[38] Paul Schoenhagen,et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. , 2005, The New England journal of medicine.
[39] W. Currenti,et al. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[40] A. Briasoulis,et al. Association between various anthropometric measures of obesity and markers of subclinical atherosclerosis , 2016, Expert review of cardiovascular therapy.
[41] M. Blaha,et al. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. , 2009, Atherosclerosis.
[42] S. R. Ferreira,et al. Methods of estimation of visceral fat: advantages of ultrasonography. , 2003, Obesity research.
[43] Klaus Mann,et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.
[44] S. Grundy,et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[45] P. Ridker,et al. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. , 2001, The American journal of cardiology.
[46] S. Virani,et al. Novel markers of inflammation in atherosclerosis , 2008, Current atherosclerosis reports.
[47] A. Khera,et al. The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. , 2007, Journal of the American College of Cardiology.
[48] E. Lonn,et al. The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. , 2009, Atherosclerosis.
[49] J. J. Rivera,et al. Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical Atherosclerosis: Implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[50] A. Sharma,et al. Obesity, hypertension and insulin resistance , 2005, Acta Diabetologica.
[51] Daniel S Berman,et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. , 2011, Journal of the American College of Cardiology.
[52] Moyses Szklo,et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Archives of internal medicine.
[53] Obesity in Adults,et al. Identification, Evaluation, and Treatment of Overweight and Obesity , 2021, Obesity Prevention and Treatment.
[54] S. Piro,et al. HbA1c Identifies Subjects With Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction , 2017, The Journal of clinical endocrinology and metabolism.
[55] V. Mooser,et al. Surrogate Markers for Atherosclerosis in Overweight Subjects With Atherogenic Dyslipidemia: The GEMS Project , 2008, Angiology.
[56] H. Hecht. Coronary artery calcium scanning: past, present, and future. , 2015, JACC. Cardiovascular imaging.